ALBANY, N.Y., Oct. 29, 2014 /PRNewswire/ -- Albany
Molecular Research Inc. (NASDAQ: AMRI) announced today that
William S. Marth, President and
Chief Executive Officer at AMRI, will present at the 2014 Credit
Suisse Healthcare Conference on Wednesday,
November 12, 2014 at 2:00 p.m.
MT.
A live audio webcast of the presentation can be accessed at
AMRI's Investor Relations web site at
http://ir.amriglobal.com/events.cfm?CalendarID=2
The webcast will be archived for 90 days following the live
presentation.
About AMRI
Albany Molecular Research Inc. (AMRI) is a global contract
research and manufacturing organization that has been working with
the Life Sciences industry to improve patient outcomes and the
quality of life for more than two decades. With locations in
North America, Europe and Asia, our key business segments include Large
Scale Manufacturing (LSM) and Discovery and Development Solutions
(DDS). The LSM segment includes Active Pharmaceutical Ingredients
(API) and Drug Product Manufacturing, which supports the commercial
cGMP manufacturing of complex APIs, starting materials, clinical
formulation development and aseptic fill and finish. Our DDS
segment provides comprehensive services from hit identification to
IND, including expertise with diverse chemistry, library design and
synthesis, in vitro biology and pharmacology, drug
metabolism and pharmacokinetics, as well as natural products. For
more information about AMRI, please visit our website at
www.amriglobal.com or follow us on Twitter (@amriglobal).
SOURCE AMRI